Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.44 |
| ▸ | SGK1 | O00141 | 1/20 | 0.40 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.37 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.37 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22043864 | 0.86 | ALDH1A1 (0.52) | CSNK2A1TAAR1ALDH1A1HSD17B10BACE1 | |
| SCHEMBL17454559 | 0.85 | TAAR1 (0.52) | CSNK2A1TAAR1ALDH1A1HSD17B10DPP4 | |
| SCHEMBL3790606 | 0.84 | LOXL2 (0.54) | CSNK2A1TAAR1ALDH1A1BACE1LOXL2 | |
| SCHEMBL3783312 | 0.84 | CSNK2A1 (0.65) | CSNK2A1TAAR1ALDH1A1HSD17B10BACE1 | |
| SCHEMBL3783088 | 0.84 | ALDH1A1 (0.50) | CSNK2A1TAAR1ALDH1A1HSD17B10BACE1 | |
| SCHEMBL27508195 | 0.83 | CSNK2A1 (0.69) | CSNK2A1TAAR1BACE1DPP4LOXL2 | |
| SCHEMBL3790111 | 0.83 | MAP4K4 (0.46) | CSNK2A1TAAR1LOXL2HRH3 | |
| SCHEMBL21708360 | 0.82 | ALDH1A1 (0.48) | CSNK2A1ALDH1A1HSD17B10BACE1 | |
| SCHEMBL28184247 | 0.82 | ALDH1A1 (0.48) | CSNK2A1TAAR1ALDH1A1HSD17B10BACE1 | |
| SCHEMBL3785443 | 0.82 | ALDH1A1 (0.54) | CSNK2A1TAAR1ALDH1A1HSD17B10LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CSNK2A1 4767/4885TAAR1 1746/4885ALDH1A1 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.